SMARCA4:

Xiaoshan Cai1, Shanshan Liu2, Linqian Li3

  • 1Department of Pathology, Weifang No. 2 People's Hospital, Weifang Respiratory Disease Hospital, Weifang, Shandong 261041, P.R. China.

Oncology letters
|December 12, 2025
PubMed
概括

这项研究详细介绍了一种罕见的,激进的小肠癌,即SMARCA4缺陷不分化癌 (SMARCA4-DUC),这种癌症迅速进展,并在43天内导致死亡. 该案突出了这种恶性瘤的独特特征和潜在的治疗点.